Pre-clinical impact of the synergistic mechanism of daptomycin and ceftaroline in patients with methicillin-resistant Staphylococcus aureus bacteremia infections
Current clinical pharmacology | 12 Jan 2021
J Eliazar, T Johnson and C Chbib
Our study aims at assessing the pre-clinical impact of the synergistic mechanism of Daptomycin (DAP) and Ceftaroline (CFT) in patients with Methicillin-resistant Staphylococcus aureus bacteremia infections (MRSAB).
* Data courtesy of Altmetric.com